Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease-Reference-Cited by-同舟云学术

Automated Neuromelanin Imaging as a Diagnostic Biomarker for Parkinson's Disease

Published:2015-03-15 Issue:7 Volume:30 Page:945-952
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Castellanos Gabriel¹²,Fernández-Seara María A.¹²,Lorenzo-Betancor Oswaldo³²,Ortega-Cubero Sara³²,Puigvert Marc⁴,Uranga Javier⁵,Vidorreta Marta¹,Irigoyen Jaione¹³²⁶,Lorenzo Elena³,Muñoz-Barrutia Arrate⁵⁷,Ortiz-de-Solorzano Carlos⁵,Pastor Pau³²⁶⁸,Pastor María A.¹²⁶

Affiliation:

1. Neuroimaging Laboratory, University of Navarra; Pamplona Spain

2. CIBERNED, Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas, Instituto de Salud Carlos III; Madrid Spain

3. Neurogenetics Laboratory, University of Navarra; Pamplona Spain

4. Pulmonary Department; Clínica Universidad de Navarra, University of Navarra School of Medicine; Pamplona Spain

5. Cancer Imaging Laboratory, Center for Applied Medical Research (CIMA), University of Navarra; Pamplona Spain

6. Department of Neurology; Clínica Universidad de Navarra, University of Navarra School of Medicine; Pamplona Spain

7. Bioengineering and Aerospace Engineering Department; University Carlos III of Madrid and Gregorio Marañon Health Research Institute; Madrid Spain

8. Department of Neurology; Hospital Universitari Mutua de Terrassa, University of Barcelona; Barcelona Spain

Publisher

Wiley

Subject

Clinical Neurology,Neurology

Reference48 articles.

1. Alpha-synuclein redistributes to neuromelanin lipid in the substantia nigra early in Parkinson's disease;Halliday;Brain,2005

2. Neuroanatomy and pathology of sporadic Parkinson's disease;Braak;Adv Anat Embryol Cell Biol,2009

3. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease;Sasaki;Neuroreport,2006

4. T1-weighted MRI shows stage-dependent substantia nigra signal loss in Parkinson's disease;Schwarz;Mov Disord,2011

5. Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease;Kashihara;J Clin Neurosci,2011

Cited by 144 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of Parkinson's disease in perspective of early diagnosis and translation of neurotrophic therapies;Basic & Clinical Pharmacology & Toxicology;2024-07-08

2. Regional nigral neuromelanin degeneration in asymptomatic leucine-rich repeat kinase 2 gene carrier using MRI;Scientific Reports;2024-05-09

3. PENCIL imaging: A novel approach for neuromelanin sensitive MRI in Parkinson's disease;NeuroImage;2024-05

4. Neuromelanin‐sensitive magnetic resonance imaging: Possibilities and promises as an imaging biomarker for Parkinson's disease;European Journal of Neuroscience;2024-03-05

5. The habenula in Parkinson's disease: Anatomy, function, and implications for mood disorders − A narrative review;Journal of Chemical Neuroanatomy;2024-03